ArticleAntimicrobial agents and chemotherapy2020

Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.

Matthias Rottmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.